Krystal Biotech, Inc. (KRYS) Options Statistics & Positioning
Max pain sits at $330 and the put/call open interest ratio is 0.48. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.
Data as of Oct 12, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active KRYS Contracts
| Contract | Expiration | DTE | Last | IV | Volume |
|---|---|---|---|---|---|
| KRYS $290 call | Nov 20, 2026 | 39d | $47.79 | 61.9% | 5 |
| KRYS $300 call | Oct 16, 2026 | 4d | $30.70 | 106.0% | 5 |
| KRYS $300 put | Nov 20, 2026 | 39d | $7.86 | 48.1% | 4 |
| KRYS $400 call | Oct 16, 2026 | 4d | $0.15 | 102.5% | 2 |
| KRYS $270 put | Feb 19, 2027 | 130d | $12.68 | 49.3% | 1 |
Explore KRYS Options Statistics
Upcoming Earnings
KRYS's next expected earnings date is Nov 5, 2026.
Explore the payoff profile of option on KRYS for free
Build multi-leg KRYS strategies, visualize payoffs, and scan the full US options universe with OptiView.
KRYS Options FAQ
When is KRYS's next earnings date?
KRYS's next expected earnings date is Nov 5, 2026.
How often is KRYS options data on this page updated?
All KRYS statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.
Where can I see KRYS max pain, open interest, and implied volatility in detail?
OptiView publishes dedicated KRYS pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.